Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) reported Net Equity Issued and Repurchased of $53.17 million for fiscal Q2 2026 (quarter ended Mar 31, 2026), up 13.5% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals posted Net Equity Issued and Repurchased of $241.39 million, down 43.8% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
- By fiscal year, Net Equity Issued and Repurchased came in at $429.27 million in FY2024, $3.05 million in FY2023 (-94.9%), $60 million in FY2022 (+430.7%) and $11.31 million in FY2021 (-95.5%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of $267,000 in fiscal Q1 2024 and a high of $429 million in fiscal Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 53.17 Mn |
| Dec 31, 2025 | 46.83 Mn |
| Sep 30, 2025 | 216.39 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Mar 31, 2024 | 429.00 Mn |
| Dec 31, 2023 | 267,000.00 |
| Sep 30, 2023 | 821,000.00 |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 520,000.00 |
| Dec 31, 2022 | 576,000.00 |
| Jun 30, 2022 | 56.27 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 815,000.00 |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | 2.63 Mn |
| Dec 31, 2020 | 5.10 Mn |
| Sep 30, 2019 | 271.00 |
| Dec 31, 2018 | 60.52 Mn |
| Jun 30, 2017 | -272,818.00 |
API Access
Arrowhead Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();